These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 19581669

  • 1. Food-dependent Cushing's syndrome.
    Messidoro C, Elte JW, Castro Cabezas M, van Agteren M, Lacroix A, de Herder WW.
    Neth J Med; 2009 May; 67(5):187-90. PubMed ID: 19581669
    [Abstract] [Full Text] [Related]

  • 2. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J.
    N Engl J Med; 1992 Oct 01; 327(14):981-6. PubMed ID: 1325609
    [Abstract] [Full Text] [Related]

  • 3. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
    Lacroix A, Bolté E, Tremblay J, Dupré J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R.
    N Engl J Med; 1992 Oct 01; 327(14):974-80. PubMed ID: 1325608
    [Abstract] [Full Text] [Related]

  • 4. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH.
    Croughs RJ, Zelissen PM, van Vroonhoven TJ, Hofland LJ, N'Diaye N, Lacroix A, de Herder WW.
    Clin Endocrinol (Oxf); 2000 Feb 01; 52(2):235-40. PubMed ID: 10671952
    [Abstract] [Full Text] [Related]

  • 5. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H.
    J Clin Endocrinol Metab; 2005 Mar 01; 90(3):1302-10. PubMed ID: 15585558
    [Abstract] [Full Text] [Related]

  • 6. Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion.
    Pralong FP, Gomez F, Guillou L, Mosimann F, Franscella S, Gaillard RC.
    J Clin Endocrinol Metab; 1999 Oct 01; 84(10):3817-22. PubMed ID: 10523036
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
    de Miguel V, Redal MA, Viale ML, Kahan M, Glerean M, Beskow A, Fainstein Day P.
    Medicina (B Aires); 2010 Oct 01; 70(3):254-6. PubMed ID: 20529775
    [Abstract] [Full Text] [Related]

  • 8. Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome.
    Preumont V, Mermejo LM, Damoiseaux P, Lacroix A, Maiter D.
    Horm Metab Res; 2011 Apr 01; 43(4):287-91. PubMed ID: 21264796
    [Abstract] [Full Text] [Related]

  • 9. [Food-dependent Cushing syndrome of long standing with mild clinical features].
    Gerl H, Rohde W, Biering H, Schulz N, Lochs H.
    Dtsch Med Wochenschr; 2000 Dec 22; 125(51-52):1565-8. PubMed ID: 11199448
    [Abstract] [Full Text] [Related]

  • 10. Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results.
    Albiger NM, Occhi G, Mariniello B, Iacobone M, Favia G, Fassina A, Faggian D, Mantero F, Scaroni C.
    Eur J Endocrinol; 2007 Dec 22; 157(6):771-8. PubMed ID: 18057385
    [Abstract] [Full Text] [Related]

  • 11. The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies.
    Lacroix A, N'Diaye N, Mircescu H, Tremblay J, Hamet P.
    Braz J Med Biol Res; 2000 Oct 22; 33(10):1201-9. PubMed ID: 11004721
    [Abstract] [Full Text] [Related]

  • 12. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
    Iida K, Kaji H, Matsumoto H, Okimura Y, Abe H, Fujisawa M, Kamidono S, Chihara K.
    Clin Endocrinol (Oxf); 1997 Dec 22; 47(6):739-45. PubMed ID: 9497882
    [Abstract] [Full Text] [Related]

  • 13. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome.
    N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A.
    J Clin Endocrinol Metab; 1999 Aug 22; 84(8):2616-22. PubMed ID: 10443649
    [Abstract] [Full Text] [Related]

  • 14. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.
    Lampron A, Bourdeau I, Hamet P, Tremblay J, Lacroix A.
    J Clin Endocrinol Metab; 2006 Sep 22; 91(9):3611-8. PubMed ID: 16772347
    [Abstract] [Full Text] [Related]

  • 15. Abnormal expression and function of hormone receptors in adrenal Cushing's syndrome.
    Lacroix A, N'Diaye N, Mircescu H, Hamet P, Tremblay J.
    Endocr Res; 1998 Sep 22; 24(3-4):835-43. PubMed ID: 9888584
    [Abstract] [Full Text] [Related]

  • 16. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients.
    Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, Narboni G, Mahoudeau J, Saez JM.
    J Clin Endocrinol Metab; 1998 Dec 22; 83(12):4514-9. PubMed ID: 9851802
    [Abstract] [Full Text] [Related]

  • 17. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
    N'Diaye N, Tremblay J, Hamet P, De Herder WW, Lacroix A.
    J Clin Endocrinol Metab; 1998 Aug 22; 83(8):2781-5. PubMed ID: 9709947
    [Abstract] [Full Text] [Related]

  • 18. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing's syndrome.
    Lacroix A.
    Eur J Endocrinol; 2023 Mar 02; 188(3):R56-R72. PubMed ID: 36857084
    [Abstract] [Full Text] [Related]

  • 19. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
    Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Perraudin V, Bertherat J, Lefebvre H.
    J Endocrinol; 2008 Jan 02; 196(1):1-9. PubMed ID: 18180312
    [Abstract] [Full Text] [Related]

  • 20. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?
    Swords FM, Aylwin S, Perry L, Arola J, Grossman AB, Monson JP, Clark AJ.
    J Clin Endocrinol Metab; 2005 May 02; 90(5):3009-16. PubMed ID: 15705925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.